Pure red-cell aplasia and recombinant erythropoietin [1] (multiple letters)

New England Journal of Medicine

Volumn 346, Issue 20, 2002, Pages 1584-1586

  Gershon, Sharon K ^a   Luksenburg, Harvey ^a   Coté, Timothy ^a   Braun, M Miles ^a   Sokol, Lubomir ^a   Prchal, Josef T ^a   Casadevall, Nicole ^a   Mayeux, Patrick ^a   Bunn, H Franklin ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; NEUTRALIZING ANTIBODY; RECOMBINANT ERYTHROPOIETIN; ERYTHROPOIETIN; AUTOANTIBODY;

ADULT; ANTIBODY DETECTION; ATHEROSCLEROSIS; CLINICAL ARTICLE; DRUG MARKETING; ERYTHROCYTE APLASIA; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERTENSION; LETTER; MALE; PRIORITY JOURNAL; THROMBOSIS; ANEMIA; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DRUG SURVEILLANCE PROGRAM; IMMUNOLOGY; MIDDLE AGED; NOTE; PURE RED CELL ANEMIA; UNITED STATES; ARTERIOSCLEROSIS; CARDIOVASCULAR SYSTEM; DRUG EFFECT; RENAL REPLACEMENT THERAPY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANEMIA; EPOETIN ALFA; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RED-CELL APLASIA, PURE; UNITED STATES; ARTERIOSCLEROSIS; AUTOANTIBODIES; CARDIOVASCULAR SYSTEM; RENAL DIALYSIS;

EID: 0037118290     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200205163462015     Document Type: Letter

References (0)